TEDOPI: A Patented Combination Of 10 Neo-Epitopes. TEDOPI...

TEDOPI: A Patented Combination Of 10 Neo-Epitopes. TEDOPI Is Being Evaluated In NSCLC After Checkpoint Inhibitor Failure
Annual Meeting Photo

Annual Meeting
3 años 84 Visitas
Categoría:
Descripción:
Alexis Peyroles MBA CEO Of OSE Immunotherapeutics Discusses TEDOPI: A Patented Combination Of 10 Neo-Epitopes. TEDOPI Is Being Evaluated In NSCLC After Checkpoint Inhibitor Failure.